← All trials
NCT04545008
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2020
- Primary completion
- Mar 31, 2021
- Completion date
- Aug 31, 2021
- First posted
- Sep 10, 2020
- Last posted
- Sep 10, 2020
- Enrollment
- 42
- Arms / groups
- 12 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Prisma HealthLead sponsor
- Clemson UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.